MAR vs TERN · P/E 32, rev $26.19B vs $6.12B cap
Marriott International Inc (MAR) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Marriott International Inc (MAR) is a lodging company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
MAR currently screens at market cap $76.70B and trailing P/E 31.9. TERN currently screens at market cap $6.12B.
Not investment advice. Open the MAR and TERN stock pages for the full models.
Not investment advice.